Lexeo Therapeutics, Inc.
LXEO • NASDAQ
Lexeo Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO R. Nolan Townsend, with a market cap of $398.5M.
CEOR. Nolan Townsend
Next Earnings
Upcoming earnings announcement for Lexeo Therapeutics, Inc.
Date
Monday, May 11, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.33
Earnings History
Past 9 earnings reports for Lexeo Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 2025 | Q3 2025 | -$0.33Est: -$0.46 | +28.3% | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.60Est: -$0.65 | +7.7% | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.99Est: -$0.77 | -28.6% | - | — | 10-Q/A |
| Mar 24, 2025 | Q4 2025 | -$0.78Est: -$0.78 | 0.0% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.89Est: -$0.68 | -30.9% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.64Est: -$0.79 | +19.0% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.77Est: -$0.77 | 0.0% | - | — | 10-Q |
| Mar 11, 2024 | Q4 2024 | -$0.86Est: -$0.73 | -17.8% | - | — | 10-K |
| Dec 11, 2023 | Q3 2023 | -$12.36 | — | - | — | — |